NCIC CTG IND.181: Phase I study of AT9283 given as a weekly 24 hour infusion in advanced malignancies
暂无分享,去创建一个
K. Gelmon | L. Seymour | J. Lyons | D. Jonker | K. Chi | S. Dent | E. Chen | N. Wainman | C. A. Capier | L. Seymour | E. Chen | Kim N. Chi | Susan Dent | Derek J. Jonker | John Lyons